Patents by Inventor Philip Gotwals

Philip Gotwals has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for the treatment of inflammatory disorders
    Patent number: 9902774
    Abstract: A method for the treatment of inflammatory disorders is disclosed, particularly the treatment of arthritis. The method comprises the administration of a function blocking antibody which is capable of binding an epitope of VLA-1.
    Type: Grant
    Filed: September 9, 2013
    Date of Patent: February 27, 2018
    Assignee: BIOGEN MA INC.
    Inventors: Antonin De Fougerolles, Philip Gotwals, Roy R. Lobb, Victor E. Kotelianski
  • METHOD FOR THE TREATMENT OF INFLAMMATORY DISORDERS
    Publication number: 20140154259
    Abstract: A method for the treatment of inflammatory disorders is disclosed, particularly the treatment of arthritis. The method comprises the administration of a function blocking antibody which is capable of binding an epitope of VLA-1.
    Type: Application
    Filed: September 9, 2013
    Publication date: June 5, 2014
    Applicant: BIOGEN IDEC MA INC.
    Inventors: ANTONIN DE FOUGEROLLES, Philip Gotwals, Roy R. Lobb, Victor E. Kotelianski
  • Method for the treatment of inflammatory disorders
    Patent number: 8557240
    Abstract: A method for the treatment of inflammatory disorders is disclosed, particularly the treatment of arthritis. The method comprises the administration of a function blocking antibody which is capable of binding an epitope of VLA-1.
    Type: Grant
    Filed: November 15, 2011
    Date of Patent: October 15, 2013
    Assignee: Biogen IDEC MA Inc.
    Inventors: Philip Gotwals, Antonin de Fougerolles, Roy Lobb, Victor E. Kotelianski
  • METHOD FOR THE TREATMENT OF INFLAMMATORY DISORDERS
    Publication number: 20120087925
    Abstract: A method for the treatment of inflammatory disorders is disclosed, particularly the treatment of arthritis. The method comprises the administration of a function blocking antibody which is capable of binding an epitope of VLA-1.
    Type: Application
    Filed: November 15, 2011
    Publication date: April 12, 2012
    Applicant: BIOGEN IDEC MA INC.
    Inventors: Philip Gotwals, Antonin de Fougerolles, Roy Lobb, Victor Kotelianski
  • Method for the treatment of inflammatory disorders
    Patent number: 8084031
    Abstract: A method for the treatment of inflammatory disorders is disclosed, particularly the treatment of arthritis. The method comprises the administration of a function blocking antibody which is capable of binding an epitope of VLA-1.
    Type: Grant
    Filed: November 11, 2008
    Date of Patent: December 27, 2011
    Assignee: Biogen Idec MA Inc.
    Inventors: Philip Gotwals, Antonin De Fougerolles, Roy Lobb, Victor Kotelianski
  • METHOD FOR THE TREATMENT OF INFLAMMATORY DISORDERS
    Publication number: 20090324598
    Abstract: A method for the treatment of inflammatory disorders is disclosed, particularly the treatment of arthritis. The method comprises the administration of a function blocking antibody which is capable of binding an epitope of VLA-1.
    Type: Application
    Filed: November 11, 2008
    Publication date: December 31, 2009
    Applicant: Biogen Idec MA Inc.
    Inventors: Philip Gotwals, Antonin De Fougerolles, Roy Lobb, Victor Kotelianski
  • Method for the treatment of inflammatory disorders
    Patent number: 7462353
    Abstract: A method for the treatment of inflammatory disorders is disclosed, particularly the treatment of arthritis. The method comprises the administration of a function blocking antibody which is capable of binding an epitope of VLA-1.
    Type: Grant
    Filed: April 18, 2005
    Date of Patent: December 9, 2008
    Assignee: Biogen Idec MA Inc.
    Inventors: Philip Gotwals, Antonin DeFougerolles, Roy Lobb, Victor Koteliansky
  • Method for the treatment of fibrosis
    Publication number: 20070048321
    Abstract: Disclosed is a method of treating fibrosis in a human or animal subject. The method comprises administering to the subject an effective amount of an antibody to an integrin or fragment thereof.
    Type: Application
    Filed: October 24, 2006
    Publication date: March 1, 2007
    Inventors: Philip Gotwals, Victor Kotelianski
  • Method for the treatment of fibrosis
    Publication number: 20050281818
    Abstract: Disclosed is a method of treating fibrosis in a human or animal subject. The method comprises administering to the subject an effective amount of an antibody to an integrin or fragment thereof.
    Type: Application
    Filed: July 28, 2005
    Publication date: December 22, 2005
    Applicant: BIOGEN IDEC MA INC.
    Inventors: Philip Gotwals, Victor Kotelianski
  • Method for the treatment of inflammatory disorders
    Patent number: 6955810
    Abstract: A method for the treatment of inflammatory disorders is disclosed, particularly the treatment of arthritis. The method comprises the administration of a function blocking antibody which is capable of binding an epitope of VLA-1.
    Type: Grant
    Filed: November 30, 2001
    Date of Patent: October 18, 2005
    Assignee: Biogen Idec, Inc.
    Inventors: Philip Gotwals, Antonin DeFougerolles, Roy Lobb, Victor Kotelianski
  • Method for the treatment of inflammatory disorders
    Publication number: 20050226877
    Abstract: A method for the treatment of inflammatory disorders is disclosed, particularly the treatment of arthritis. The method comprises the administration of a function blocking antibody which is capable of binding an epitope of VLA-1.
    Type: Application
    Filed: April 18, 2005
    Publication date: October 13, 2005
    Applicant: BIOGEN IDEC, INC.
    Inventors: Philip Gotwals, Antonin DeFougerolles, Roy Lobb, Victor Kotelianski
  • Type II TGF-beta receptor/immunoglobulin constant region fusion proteins
    Publication number: 20050203022
    Abstract: Fusion proteins comprising the TGF-beta Type II receptor linked to a portion of an immunoglobulin constant chain are described. Also described are methods of using the fusion proteins of the invention to treat a variety of fibroproliferative disorders.
    Type: Application
    Filed: April 18, 2005
    Publication date: September 15, 2005
    Applicant: BIOGEN IDEC, INC.
    Inventors: Philip Gotwals, Victor Koteliansky, Richard Cate, Michelle Sanicola-Nadel
  • Global expression analysis of extracellular matrix-integrin interactions in monocytes
    Publication number: 20030124726
    Abstract: Disclosed are methods of identifying integrin modulating agents using differential gene expression. Also disclosed are method of treating atheroscerosis and inflammatory disorders in a subject.
    Type: Application
    Filed: August 3, 2001
    Publication date: July 3, 2003
    Inventors: Antonin deFougerolles, Philip Gotwals, Cynthia Green, Victor Koteliansky
  • Method for the treatment of inflammatory disorders
    Publication number: 20020146417
    Abstract: A method for the treatment of inflammatory disorders is disclosed, particularly the treatment of arthritis. The method comprises the administration of a function blocking antibody which is capable of binding an epitope of VLA-1.
    Type: Application
    Filed: November 30, 2001
    Publication date: October 10, 2002
    Inventors: Philip Gotwals, Antonin De Fougerolles, Roy Lobb, Victor Kotelianski
  • Variant type II TGF-beta receptor fusion proteins and methods
    Publication number: 20020004037
    Abstract: Fusion proteins comprising a variant form of TGF-beta Type II receptor linked to a portion of an immunoglobulin constant chain are described. Also described are methods of using the fusion proteins of the invention to treat a variety of fibroproliferative disorders.
    Type: Application
    Filed: December 11, 2000
    Publication date: January 10, 2002
    Inventors: Victor Koteliansky, Philip Gotwals, Richard Cate, Michele Sanicola-Nadel